PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 4, 2024JCI Insight16 citationsOpen Access

Heterogeneous SARS-CoV-2 kinetics due to variable timing and intensity of immune responses

View Full Paper
KOKatherine OwensSEShadisadat EsmaeiliJSJoshua T. Schiffer

Key Points

Key points are not available for this paper at this time.

Abstract

The viral kinetics of documented SARS-CoV-2 infections exhibit a high degree of inter-individual variability. We identified six distinct viral shedding patterns, which differed according to peak viral load, duration, expansion rate and clearance rate, by clustering data from 768 infections in the National Basketball Association cohort. Omicron variant infections in previously vaccinated individuals generally led to lower cumulative shedding levels of SARS-CoV-2 than other scenarios. We then developed a mechanistic mathematical model that recapitulated 1510 observed viral trajectories, including viral rebound and cases of reinfection. Lower peak viral loads were explained by a more rapid and sustained transition of susceptible cells to a refractory state during infection, as well as an earlier and more potent late, cytolytic immune response. Our results suggest that viral elimination occurs more rapidly during omicron infection, following vaccination, and following re-infection due to enhanced innate and acquired immune responses. Because viral load has been linked with COVID-19 severity and transmission risk, our model provides a framework for understanding the wide range of observed SARS-CoV-2 infection outcomes.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Owens et al. (2024) studied this question.

synapsesocial.com/papers/68e7055ab6db64358767f9fehttps://doi.org/10.1172/jci.insight.176286
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-192020 · 4,568 citations
  2. 2Windows of opportunity for Ebola virus infection treatment and vaccination2017 · 39 citations
  3. 3CMV viral load kinetics as surrogate endpoints after allogeneic transplantation2020 · 57 citations
  4. 4In vivo kinetics of SARS-CoV-2 infection and its relationship with a person’s infectiousness2021 · 185 citations
  5. 5Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study2021 · 66 citations